Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656031


The North America Biotechnology Sectors : A Company and Industry Analysis (September 2004)


Description: This report looks at the biotechnology sectors in the United States and Canada, including the research, development and manufacturing and marketing and distribution segments
Current Environment - Key Points
- The strong rebound in the global biotech industry continued into the first half of 2004, driven largely by product successes
Publicly traded biotech companies registered an improvement of 65% in their net losses while increasing their employment by 9% during the year
- In the US, the increase in new product approvals and promising results in clinical trials of experimental drugs have accelerated the recovery of the biotech sector
- Pharmaceutical companies in the US are increasingly carrying out mergers and acquisitions with biotech companies to fill their pipelines with new drugs and replicate their initial successful earnings
- The Canadian biotech sector experienced a strong rebound in 2003, with revenues of public biotech companies climbing 18% to US$1.73 million
- While the Canadian biotech sector is fundamentally strong, its continued financial health faces significant challenges
Cash positions of public biotech companies continued to deteriorate and net loss of the sector surged 123% to US$586 million in 2003

Industry Profile - Key Points
- As of mid March 2004, the market capitalization of publicly traded biotech companies in the US was $311 billion, up nearly 51% from $206 billion recorded in 2003
- Venture capital investment in the US biotech sector has remained robust over the last few years
Investments in the biotech sector accounted for more than 20% of all venture capital investments in the US in the first quarter of 2004
- Employment in the biotech sector grew 6.3% in 2003 after increasing by 12% in the 2000 to 2002 period, representing the fastest growth for any major industry in the US
- The Canadian biotech industry ranks second only to the US in the number of biotech companies, and generates revenues that rank third globally, behind the US and the UK
- The number of biotech companies grew 12.7% from the previous year to 470 companies in 2003, with about 17% of them being publicly traded
Market Trends and Outlook - Key Points
- The increase in the world's population and the need to increase food production to meet rising demand has given rise to the rapid adoption of biotech by farmers around the world
- Ageing populations in many countries has driven the increase in global health care expenditure, expanding market opportunities enormously for biotech drugs and treatments
- As biotech food products become part of agricultural international trade, consumers- opinions on safety and necessity of biotech food products have become a dominant force behind changing agricultural trade policies
- The outlook for the US biotech sector should remain positive throughout 2004, buoyed by the recovery of the US economy and improvements in the capital markets
- As the patents of many biotech drugs expire in the next several years, generic drugmakers will jump into the market with therapeutic equivalents
- The growing complexity, demand and cost of new generations of drugs is expected to continue to accelerate the development of plant-generated biopharmaceuticals


Contents: Current Environment - US
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers and Acquisitions
Current Environment - Canada
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers and Acquisitions
Industry Profile - US
- Industry Size and Value
- Industry Focus
- Venture Capital Investment
- Research and Development
- Government Investment
- Policy and Regulatory
Environment
Industry Profile - Canada
- Industry Size and Value
- Industry Focus
- Venture Capital Investment
- Research and Development
- Government Investment
- Policy and Regulatory
Environment
Market Trends & Outlook - US
- Biotech Crops on the Rise
- Ageing Population Leading
to Growth of Pharmaceutical
Biotech
- US-European Trade Dispute Hits
the Sector
- Market Outlook - United States
Market Trends & Outlook -
Canada
- Growth of Generic
Biopharmaceuticals
- Potential of Plant-Generated
Pharmaceuticals
- Market Outlook - Canada
Currency Conversion Table
The Scope of this Report
Key References
Comparative Data
Sales Contacts




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656031

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 24/11/2009 17:21:59
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The North America Biotechnology Sectors : A Company and Industry Analysis (September 2004)
Web Address:
http://www.researchandmarkets.com/reports/656031
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €100.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 24/11/2009 17:21:59

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)